Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
DERM	Journey Medical Corp Manufacturing · Year ended 2025-12-31 · USD	$61.24M	-$11.43M	-18.7%	-35.9%	11.1%	-$0.47
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
GYRE	Gyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$116.59M	$9.88M	8.5%	9.3%	10.2%	$0.02
FBIO	Fortress Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$63.26M	$6.82M	10.8%	13.7%	9.7%	-$0.07
VRTX	Vertex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$12.00B	$3.95B	32.9%	21.2%	8.9%	$15.32
VNDA	Vanda Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$216.10M	-$220.47M	-102.0%	-67.4%	8.7%	-$3.74
SUPN	Supernus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$718.95M	-$38.55M	-5.4%	-3.6%	8.6%	-$0.68
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
AMRX	Amneal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02B	$72.06M	2.4%	n/a	8.0%	$0.22
ETST	Earth Science Tech, Inc. Manufacturing · Year ended 2026-03-31 · USD	$35.70M	$3.63M	10.2%	51.8%	7.8%	$0.012
HRTX	Heron Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$154.90M	-$20.20M	-13.0%	-140.9%	7.4%	-$0.12
SVA	Sinovac Biotech Ltd Manufacturing · Year ended 2025-12-31 · USD	$386.01M	-$198.84M	-51.5%	-3.1%	6.8%	-$0.83
BHC	Bausch Health Companies Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.27B	$120.00M	1.2%	31.8%	6.7%	$0.42
ELAN	Elanco Animal Health Inc Manufacturing · Year ended 2025-12-31 · USD	$4.71B	-$232.00M	-4.9%	-3.5%	6.2%	-$0.47
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
NATR	Nature's Sunshine Products Inc Manufacturing · Year ended 2025-12-31 · USD	$480.14M	$20.45M	4.3%	12.7%	5.7%	$1.06
ABT	Abbott Laboratories Manufacturing · Year ended 2025-12-31 · USD	$44.33B	$6.52B	14.7%	12.5%	5.7%	$3.72
RPRX	Royalty Pharma plc Manufacturing · Year ended 2025-12-31 · USD	$2.38B	$770.95M	32.4%	7.9%	5.1%	$1.78
JAZZ	Jazz Pharmaceuticals plc Manufacturing · Year ended 2025-12-31 · USD	$4.27B	-$356.15M	-8.3%	-8.2%	4.9%	-$5.84
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21
INDV	Indivior Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.24B	$210.00M	16.9%	n/a	4.3%	$1.64
EVFM	Evofem Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.18M	$391.0K	1.9%	n/a	4.2%	$0.00
SBFM	Sunshine Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.31M	-$5.98M	-16.5%	-25.9%	4.1%	n/a
KRSA	Korsana Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.07M	-$3.53M	-170.1%	-38.8%	3.7%	-$1.11
PCRX	Pacira BioSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$726.41M	$7.03M	1.0%	1.0%	3.6%	$0.16

Rows per page: 2550 100